The annual SHPBest™ recognition program was created to acknowledge home health and hospice providers that consistently provide high quality service. SHP would like to congratulate the 2018 SHP Best-of-the-Best winners, who have been recognized for achieving the highest overall HHCAHPS patient satisfaction or CAHPS Hospice caregiver satisfaction scores of all eligible SHP clients during the 2018 calendar year.
The home health industry is six months away from the new Patient-Driven Grouping Model (PDGM). There is a lot of educational content available to help agencies prepare but much of it reports on PDGM metrics and payments using average values. Using 30-day periods as an overall average can be misleading. It is more meaningful to break out this data into the sequence of periods across groupings like clinical category. In this way one can analyze the impacts of periods to help define the clinical and operational improvements necessary to manage your agencies under PDGM.
On April 25th, the Centers for Medicare & Medicaid Services (CMS) posted their proposed FY 2020 payment rule for hospice on the Federal Register. In our blog we summarize what you need to know such as the potential rate impact between 2019 and 2020, additions to Hospice Compare, and new “high priority” measures they are considering adding to their Hospice Quality Reporting transparency.
Given the significant role that hospitalization rates play in publicly reported scores, star ratings, and value-based purchasing calculations, preventing unplanned hospitalizations is one of the top priorities for home health agencies. To ensure that our clients have the best possible tools to identify patients that are at risk of being hospitalized and help prevent unplanned hospitalizations, SHP has released a major update to our acute care hospitalization risk model.
An informative report from the United Hospital Fund described the overly complex process patients and their families go through to navigate Post-Acute Care (PAC) options such as skilled nursing facilities (SNF) and home health agencies (HHA) after a hospital stay. SHP's CareStat product addresses current challenges with transitioning care by providing hospitals and ACOs with real-time home quality and patient data.
Now that we know the Patient-Driven Groupings Model (PDGM) will officially start January 1, 2020, it’s time to dig a little deeper into understanding how the case-mix weights of the 432 PDGM groups were established.
The CY 2019 Home Health Payment System Rate final rule was published last week and, as expected, the Patient-Driven Groupings Model (PDGM) will be implemented for 30-day periods of care starting on or after January 1, 2020. In our blog we provide a summary of changes to the model, such as the expansion of clinical groups from six to twelve, as well as home health PPS Case-mix updates and significant HHVBP changes confirmed in the final rule.
We are excited to announce the release of the Hospitalization Patient Detail report to our SHP for Agencies customers. This powerful new report provides a complete picture of the home-health stay for any patient, including: hospitalization risk, transfer history, and discharge details, with one row of data for each SOC/ROC to any available Transfer/Discharge. Also included are indicators for 30-Day Rehospitalizations, 60-Day Hospitalizations, Emergent Care, Hospitalization outcome details, and more.
In the CY 2018 Home Health Proposed Rule, CMS is dramatically changing the scoring methodology for the pilot program known as the Home Health Value-based Purchasing Program (HHVBP). What is striking to me is that these changes are being made during the fourth year of the five-year program, where up to 7% of Medicare revenues are at risk.
In the CY 2019 Home Health Proposed Rule, CMS shared a level of detail not seen before – an agency specific list of how agencies will fare under the changes they are proposing. Wow. CMS shared the agency revenue impacts of the Patient-Driven Groupings Model (PDGM) versus the current 153-group PPS reimbursement revenue. The range of the revenue impact is quite wide. Looking at the SHP national database for CY 2017, about 17% of the 3.6MM payment episodes in our database had a primary diagnosis code that would be considered a QE under PDGM.